The filing

Please find enclosed herewith the Outcome of the Board Meeting held on September 28, 2026 pursuant to the Change in Control of the Company.

Company

Bliss GVS Pharma Ltd · BSE 506197

Filed

28 September 2026, 20:32 IST

BSE category

Company Update / Change in Management Control

Tag

Change in Control · selected

Source

Open the filing on BSE →

Why it led

• Change in Control is rare - fewer than one filing in two hundred
• First Change in Control from this company — not seen in the 93 trading days on record
• Small cap

Selected by the ranker from 40 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

13 of 90,553 filings in the published window carry Change in Control · 0.01%

Around it

Also filed by Bliss GVS Pharma Ltd on 28 September 2026

• Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, October 01, 2026 Board Meeting21:02 IST
• Meeting Updates Meeting Update20:53 IST
• Meeting Updates Meeting Update20:48 IST
• Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"). Outcome20:28 IST

Most recent filings from Bliss GVS Pharma Ltd

• Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Compliance Certificate6 October 2026 · 15:27 IST
• Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 SAST6 October 2026 · 10:26 IST
• Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") Board Outcome1 October 2026 · 19:46 IST